Skip to main content

Table 3 Univariate and Multivariate Cox Regression Models to Identify Predictors for appropriate ICD therapy in All Patients

From: Outcomes of Cardiac Resynchronization Therapy in Patients with Hypothyroidism and Heart Failure

Variable

Univariate Analysis

Multivariate Analysis

HR

95% CI

P Value

HR

95% CI

P Value

Age

0.99

0.98–1.00

0.08

   

Female

0.41

0.29–0.59

< 0.001

0.45

0.27–0.75

0.002

Primary prevention

0.54

0.40–0.72

< 0.001

0.28

0.10–0.83

0.02

Hypertension

1.04

0.81–1.32

0.78

   

Diabetes mellitus

1.01

0.78–1.32

0.92

   

Chronic kidney disease

1.24

0.94–1.63

0.13

   

Hyperlipidemia

1.09

0.86–1.39

0.48

   

Atrial fibrillation

1.20

0.94–1.53

0.14

   

ICM

1.13

0.89–1.44

0.32

   

LBBB

0.67

0.52–0.85

0.001

0.72

0.50–1.05

0.08

QRS duration

0.997

0.992–1.001

0.17

   

NYHA functional class

1.16

0.91–1.47

0.24

   

LVEF

0.98

0.96–1.00

0.02

0.97

0.95–1.01

0.11

TRT

0.97

0.71–1.32

0.84

   

Statin

1.02

0.80–1.30

0.87

   

amiodarone

1.62

1.22–2.15

0.001

0.44

0.16–1.27

0.13

Digoxin

1.55

1.22–1.97

< 0.001

1.44

1.00–2.07

0.05

ACEARB

0.77

0.57–1.05

0.09

0.73

0.45–1.18

0.20

Aldactone

1.07

0.82–1.38

0.62

   

Furosemide

1.30

0.99–1.71

0.06

1.13

0.75–1.70

0.54

CRT response

0.43

0.32–0.59

< 0.001

0.46

0.32–0.68

< 0.001

TSH per 5 mIU/L

1.05

1.02–1.09

0.002

1.23

1.01–1.50

0.04

  1. Abbreviations as in Table 1. TSH thyroid-stimulating hormone